Sale!

GNAI3 Gene Auriculocondylar Syndrome Type 1 Genetic Test

4,400 د.إ

-21%

The GNAI3 gene auriculocondylar syndrome type 1 genetic test is a specialized diagnostic procedure available at DNA Labs UAE. This test is specifically designed to identify mutations in the GNAI3 gene, which are known to cause auriculocondylar syndrome type 1 (ACS1). ACS1 is a rare genetic disorder characterized by malformations of the ears, mandible, and temporomandibular joint, leading to distinctive facial features and potentially impacting speech and eating.

The test is conducted through a detailed analysis of the patient’s DNA, extracted from a blood sample, to pinpoint any genetic abnormalities in the GNAI3 gene. The process involves advanced genetic sequencing technologies to ensure accurate and reliable results.

The cost of the GNAI3 gene auriculocondylar syndrome type 1 genetic test at DNA Labs UAE is set at 4400 AED. This price reflects the comprehensive nature of the test, including the sophisticated technology and expertise required to accurately diagnose this rare condition.

Opting for this test at DNA Labs UAE offers patients and their families the opportunity to gain crucial insights into the genetic basis of auriculocondylar syndrome type 1. This information can be invaluable for understanding the condition, making informed medical and lifestyle decisions, and assessing the risk of passing the gene mutation to future generations.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

GNAI3 Gene Auriculocondylar Syndrome Type 1 Genetic Test

Test Name: GNAI3 Gene Auriculocondylar Syndrome Type 1 Genetic Test

Components: DNA Labs UAE

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Dysmorphology

Doctor: Pediatrics

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for GNAI3 Gene Auriculocondylar Syndrome Type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GNAI3 Gene Auriculocondylar Syndrome Type 1 NGS Genetic DNA Test gene GNAI3.

Test Details

The GNAI3 gene is associated with Auriculocondylar Syndrome Type 1, a rare genetic disorder characterized by craniofacial abnormalities and limb malformations. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, providing a comprehensive view of an individual’s genetic makeup.

In the context of Auriculocondylar Syndrome Type 1, NGS genetic testing can be used to identify mutations or variations in the GNAI3 gene that may be responsible for the disorder. The test involves obtaining a DNA sample from the patient, usually through a blood sample or saliva sample. The DNA is then sequenced using NGS technology, which reads the genetic code and identifies any variations or mutations in the GNAI3 gene.

The results of the NGS genetic test can help confirm a diagnosis of Auriculocondylar Syndrome Type 1 and provide information about the specific genetic variant causing the disorder. This information can be useful for genetic counseling, family planning, and potentially guiding treatment decisions in the future.

Test Name GNAI3 Gene Auriculocondylar syndrome type 1 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Dysmorphology
Doctor Pediatrics
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for GNAI3 Gene Auriculocondylar syndrome type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GNAI3 Gene Auriculocondylar syndrome type 1 NGS Genetic DNA Test gene GNAI3
Test Details

The GNAI3 gene is associated with Auriculocondylar syndrome type 1, a rare genetic disorder characterized by craniofacial abnormalities and limb malformations.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, providing a comprehensive view of an individual’s genetic makeup. In the context of Auriculocondylar syndrome type 1, NGS genetic testing can be used to identify mutations or variations in the GNAI3 gene that may be responsible for the disorder.

The test involves obtaining a DNA sample from the patient, usually through a blood sample or saliva sample. The DNA is then sequenced using NGS technology, which reads the genetic code and identifies any variations or mutations in the GNAI3 gene.

The results of the NGS genetic test can help confirm a diagnosis of Auriculocondylar syndrome type 1 and provide information about the specific genetic variant causing the disorder. This information can be useful for genetic counseling, family planning, and potentially guiding treatment decisions in the future.